Chugai Pharmaceutical Co., Ltd. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Chugai Pharmaceutical Co., Ltd. (Chugai or 'the company') is involved in bio-pharmaceutical research and development. The company offers medical products and services for human health. Chugai produces antibody drugs that focus on oncology, hematology, immunology, neuroscience, infectious diseases, and joint diseases. The company's product portfolio includes Actemra (tocilizumab), Alfarol, Avastin (bevacizumab), Bonviva (ibandronate), CellCept (mycophenolate mofetil), Tamiflu (oseltamivir phosphate), Edirol (eldecalcitol), Kadcyla (trastuzumab emtansine), Kytril, and Mircera (epoetin beta pegol). Chugai operates and markets its products in North America, Europe and Asia. The company is headquartered in Tokyo, Japan.Scope
- Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Chugai Pharmaceutical Co., Ltd.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Chugai Pharmaceutical Co., Ltd.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Chugai Pharmaceutical Co., Ltd.: Company Overview
- Chugai Pharmaceutical Co., Ltd.: Overview and Key Facts
- Chugai Pharmaceutical Co., Ltd.: Overview
- Chugai Pharmaceutical Co., Ltd.: Key Facts
- Chugai Pharmaceutical Co., Ltd.: Key Employees
- Chugai Pharmaceutical Co., Ltd.: Key Employee Biographies
- Chugai Pharmaceutical Co., Ltd.: Major Products and Services
- Chugai Pharmaceutical Co., Ltd.: Management Statement
- Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries
- Chugai Pharmaceutical Co., Ltd.: Key Competitors
- Chugai Pharmaceutical Co., Ltd.: Company Analysis
- Chugai Pharmaceutical Co., Ltd.: Business Description
- Chugai Pharmaceutical Co., Ltd.: SWOT Analysis
- Chugai Pharmaceutical Co., Ltd.: SWOT Overview
- Chugai Pharmaceutical Co., Ltd.: Strengths
- Chugai Pharmaceutical Co., Ltd.: Weaknesses
- Chugai Pharmaceutical Co., Ltd.: Opportunities
- Chugai Pharmaceutical Co., Ltd.: Threats
- Chugai Pharmaceutical Co., Ltd.: Corporate Financial Deals Activity
- Chugai Pharmaceutical Co., Ltd.: Financial Deals Overview
- Chugai Pharmaceutical Co., Ltd.: Targets and Partners
- Chugai Pharmaceutical Co., Ltd.: Top Deals 2021 - 2025YTD*
- Chugai Pharmaceutical Co., Ltd.: Corporate Venturing
- Chugai Pharmaceutical Co., Ltd.: Partnership
- Chugai Pharmaceutical Co., Ltd.: Divestments
- Chugai Pharmaceutical Co., Ltd.: Recent Developments
- Chugai Pharmaceutical Co., Ltd.: News and Events Summary
- Chugai Pharmaceutical Co., Ltd.: Business Expansion
- Chugai Pharmaceutical Co., Ltd.: Corporate Governance
- Chugai Pharmaceutical Co., Ltd.: Financial Performance
- Chugai Pharmaceutical Co., Ltd.: Research & Development
- Chugai Pharmaceutical Co., Ltd.: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
Table 1: Chugai Pharmaceutical Co., Ltd.: Key Facts
Table 2: Chugai Pharmaceutical Co., Ltd.: Key Employees
Table 3: Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Table 4: Chugai Pharmaceutical Co., Ltd.: Key Competitors
Table 5: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 7: Chugai Pharmaceutical Co., Ltd.: Targets and Partners
Table 8: Chugai Pharmaceutical Co., Ltd.: Top Deals 2021 - 2025YTD*
Table 9: Chugai Pharmaceutical Co., Ltd.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Table 10: Chugai Pharmaceutical Co., Ltd.: Corporate Venturing by Geography (2021 - YTD*2025)
Table 11: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 12: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 13: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2021 - YTD*2025)
Table 14: Chugai Pharmaceutical Co., Ltd.: News and Events Summary
Table 15: Chugai Pharmaceutical Co., Ltd.: Business Expansion
Table 16: Chugai Pharmaceutical Co., Ltd.: Corporate Governance
Table 17: Chugai Pharmaceutical Co., Ltd.: Financial Performance
Table 18: Chugai Pharmaceutical Co., Ltd.: Research & Development
Table 19: Chugai Pharmaceutical Co., Ltd.: Strategy and Operations
List of Figures
Figure 1: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 3: Chugai Pharmaceutical Co., Ltd.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Figure 4: Chugai Pharmaceutical Co., Ltd.: Corporate Venturing by Geography (2021 - YTD*2025)
Figure 5: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 6: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2021 - YTD*2025)
Figure 7: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2021 - YTD*2025)
